NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









JNPMEDI

JNPMEDI

Private
IncheonHealthcare & Life Scienceshttps://www.jnpmedi.com/

Last Round

Grant

Jan 8, 2026

Est. Valuation

$37M

Total Funding Raised

$13.67M

Company Overview

JNPMEDI is a healthcare technology company that provides a cloud-based, AI-powered medical data platform for clinical research and trial operations.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

decentralized clinical trialDCTclinical trial managementelectronic data captureEDCeCOAeConsenteClinicalclinical trial softwareRTSMclinical trial automationvertical SaaSmedical coding AISDTM conversionremote patient monitoringclinical research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

JNPMEDI Comparables

Compare JNPMEDI with similar companies based on industry and business-model similarity.

JNPMEDI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CRScube
85%
ObvioHealth
80%
Curebase
80%

JNPMEDI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 8, 2026
Corporate FundingAug 13, 2025
Series ANov 22, 2022
SeedJan 18, 2022
SeedDec 8, 2021

Key People

Founding team and executive leadership

Jonghyun Park

CEO Staff

Executive Team

Kwunho Jeong

Chief Executive Officer

Executive Team

Minjung Jade Kim

CEO Staff, Product Portfolio Manager

Executive Team

Youngyong Park

Chief Technology Officer

Executive Team

JNPMEDI Investors

Notable investors and investment history

JNPMEDI investors
InvestorRounds
Kakao VenturesSeed, Series A
TBT PartnersCorporate Funding
Murex PartnersSeed, Series A
Pavilion CapitalSeries A
Gentium PartnersSeed, Series A
Government of South KoreaGrant
AJU IB InvestmentSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2021

    $1.7M round led by AJU IB Investment and Kakao Ventures.

JNPMEDI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

JNPMEDI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about JNPMEDI's valuation, stock price, and market status.

Firmographic Details

HeadquartersIncheon
Employee Range116
Year Founded2020
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.